Director, Data Sciences, Strategy & Platforms

Merck & Co., Inc.

Passionate about leveraging innovative technologies and digital  help realize the strategic vision of Real World Data (RWD) and Evidence(RWE) to improve patient health and inform the pipeline

Jennifer K. Pai, ScD is currently the Director of Data Sciences, Strategy, and Platforms at Merck & Co., Inc focused on advancing translational applications of data sciences and predictive analytics to accelerate the development of observational and real world evidence research. Previous to this role, Dr. Pai held leadership roles in the IT organization as the health informatics and data strategy lead focused broadly on enabling data interoperability, increased data utility, and analytics across the drug discovery pipeline.

Prior to joining Merck, Dr. Pai was on the faculty at Harvard Medical School where she led an independent research program evaluating novel plasma and genetic biomarkers as risk predictors of cardiovascular disease. Dr. Pai has coauthored >45 publications in leading journals and served as expert reviewer for journals, scientific conferences, and national funding agencies. She holds degrees from The Johns Hopkins University and a Doctorate degree in Epidemiology from Harvard University.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement